Roster Set For Upcoming Transvaginal Mesh Advisory Committee

An influx of adverse transvaginal mesh reports have become the subject of intense scrutiny in the healthcare community. The past two years have witnessed an exponential growth in complications associated with the surgical application of transvaginal mesh products. Due to the frequency and severity in which these adverse events are being reported, a public…

Read More

Settlement Leads to Label Changes on Brazilian Blowout Products

As a relatively new hair treatment, Brazilian Blowout boasts the ability to straighten hair, while simultaneously creating a protective and nutrient rich barrier around it. However, critics of the revolutionary hair treatment product have revealed a potentially dangerous and undisclosed mechanism of action. When introduced to direct heat, the product releases formaldehyde gas. Inhalation…

Read More

Guillain-Barré Syndrome Lawyer & Lawsuit

Guillain-Barré Syndrome is an uncommon disorder in which a person’s immune system attacks their nerves. Symptoms can spread throughout the entire body over time and lead to complete paralysis. In this article we will discuss the signs and symptoms, causes, risk factors, complications, tests and diagnosis for Guillain-Barré Syndrome. If you or a loved…

Read More

Popcorn Lung Lawsuit

Popcorn lung, otherwise known as bronchiolitis obliterans, is a rare and potentially life-threatening variation of non-reversible obstructive lung disease. Of significant concern, however, are recent reports that have established an association between this condition and the inhalation of diacetyl; a chemical used to produce the butter-like flavoring in many foods such as candy, microwave…

Read More

Triad Alcohol Prep Pads Recalled Due to Possible Microbial Contamination

In what has become the strongest action to date by the U.S. Food and Drug Administration (FDA), inspection officials implored H&P Industries, Inc. (Triad Group) to halt the production and distribution of all their drug products after the discovery of infectious bacterium agents. After FDA officials inspected facilities of the Wisconsin-based Triad Group, they…

Read More

New Study Suggests DMAA is Not a Natural Derivative of Geranium Oil

Controversy has surrounded the origins of one of the most prominent ingredients of the dietary supplement industry in recent months. Accordingly, researchers have failed to determine whether or not 1, 3 Dimethylamylamine (DMAA) is a natural derivative of geranium oil. However, the release of peer-reviewed paper may finally conclude that DMAA is synthetic production,…

Read More

New Bill Promises To Refine The Lenient 501(k) Medical Device Approval System

Allegedly lenient regulatory practices on behalf of the U.S. Food and Drug Administration (FDA) have allowed several questionable products, most notably transvaginal mesh, to reach interstate commerce. The ambiguity of such regulatory practices has demonstrated a propensity for the release of potentially dangerous devices on the U.S. market. However, a bill recently proposed by…

Read More

Army Continues DMAA Investigation Despite Halt In Public Distribution

Despite a recent moratorium implemented by the federal government on the public distribution of 1,3-dimethylamylamine (DMAA), Army officials are launching their own investigation that will continue to study the effects of the trending bodybuilding supplement. According to a statement made by the Department of Defense last Thursday, the Army plans to gain a deeper…

Read More